Grey Fox Wealth Advisors, LLC Gilead Sciences, Inc. Transaction History

Grey Fox Wealth Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 11, 2024	SELL	$71.58 - $87.29 $11,238 - $13,704	-157 Reduced 4.96%	3,006 $220 Million
Q4 2023 Jan 17, 2024	SELL	$73.27 - $83.09 $12,236 - $13,876	-167 Reduced 5.02%	3,163 $256 Million
Q3 2023 Oct 24, 2023	BUY	$73.94 - $80.67 $665 - $726	9 Added 0.27%	3,330 $250 Million
Q2 2023 Aug 03, 2023	SELL	$76.01 - $86.7 $187,288 - $213,628	-2,464 Reduced 42.59%	3,321 $256 Million
Q1 2023 May 09, 2023	SELL	$77.31 - $88.08 $22,651 - $25,807	-293 Reduced 4.82%	5,785 $480 Million
Q4 2022 Feb 14, 2023	BUY	$62.32 - $89.47 $378,780 - $543,798	6,078 New	6,078 $522 Million

1,931

991M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Grey Fox Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Grey Fox Wealth Advisors, LLC with notifications on news.